Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
2.145 EUR | +1.18% | +41.33% | -20.30% |
Mar. 25 | Advicenne: ODD designation in cystinuria | CF |
Jan. 24 | Advicenne: share price hit after 2023 sales figures | CF |
Sales 2023 * | 3.7M 3.99M | Sales 2024 * | 4.7M 5.06M | Capitalization | 26.13M 28.15M |
---|---|---|---|---|---|
Net income 2023 * | -3M -3.23M | Net income 2024 * | -8M -8.62M | EV / Sales 2023 * | 9.29 x |
Net Debt 2023 * | 8.25M 8.89M | Net Debt 2024 * | 17.4M 18.75M | EV / Sales 2024 * | 9.26 x |
P/E ratio 2023 * |
-2.87
x | P/E ratio 2024 * |
2.97
x | Employees | 19 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 88.22% |
1 day | -5.19% | ||
1 week | +34.00% | ||
Current month | +63.95% | ||
1 month | +49.78% | ||
3 months | -24.15% | ||
6 months | -13.36% | ||
Current year | -24.44% |
Managers | Title | Age | Since |
---|---|---|---|
Didier Laurens
CEO | Chief Executive Officer | 59 | 21-05-02 |
Chief Tech/Sci/R&D Officer | - | 23-03-31 | |
André Ulmann
BRD | Director/Board Member | - | 17-06-22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | - | 11-04-28 | |
Catherine Dunand
BRD | Director/Board Member | 62 | 17-03-08 |
Didier Laurens
CEO | Chief Executive Officer | 59 | 21-05-02 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 2.145 | +1.18% | 98 054 |
24-03-27 | 2.12 | +3.67% | 45,897 |
24-03-26 | 2.045 | -11.09% | 132,575 |
24-03-25 | 2.3 | +39.39% | 404,396 |
24-03-22 | 1.65 | +10.00% | 89,490 |
Real-time Euronext Paris, March 28, 2024 at 06:14 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-24.44% | 28.27M | |
+0.44% | 90.27B | |
+10.00% | 44.05B | |
-16.40% | 31.45B | |
+43.98% | 23.35B | |
-8.10% | 16.72B | |
-25.64% | 15.09B | |
-9.03% | 12.82B | |
-9.37% | 11.95B | |
+98.58% | 7.67B |